Breaking News Instant updates and real-time market news.

CUTR

Cutera

$21.32

0.35 (1.67%)

16:38
11/06/18
11/06
16:38
11/06/18
16:38

Cutera reports Q3 EPS 11c, consensus 3c

Reports Q3 revenue $40.6M, consensus $42.24M.

  • 06

    Nov

  • 06

    Nov

  • 27

    Nov

CUTR Cutera
$21.32

0.35 (1.67%)

04/16/18
STFL
04/16/18
INITIATION
Target $55
STFL
Hold
Cutera initiated with a Hold at Stifel
Stifel analyst Jonathan Black initiated Cutera with a Hold and $55 price target.
10/05/18
STFL
10/05/18
NO CHANGE
Target $29
STFL
Hold
Cutera price target lowered to $29 from $45 at Stifel
Stifel analyst Jonathan Block said that while he believes Cutera is putting the right long-term pieces in place, some initiatives may take time and he prefers to see how 2019 revenue growth plays out before he would become more constructive on the shares. The analyst, who noted that the company had previously cut its 2018 EPS view meaningfully on its Q2 earnings call prior to last night's negative pre-announcement regarding Q3, keeps a Hold rating on Cutera shares and lowered his price target to $29 from $45.
10/05/18
SPHN
10/05/18
NO CHANGE
Target $40
SPHN
Overweight
Cutera price target lowered to $40 from $50 at Stephens
Stephens analyst Chris Cooley noted that Cutera's Q3 negative pre-announcement marked the third consecutive quarterly shortfall for the company and he lowered his price target on the stock to $40 in reaction to the news. While he believes the shares are likely to continue to underperform through the end of the calendar year, Cooley said he is inclined to take a longer-term focus and hold rather than sell while waiting for growth to accelerate in 2019. He maintains an Overweight rating on Cutera shares, which are down 16% to $24.94 in pre-market trading.
10/10/18
SPHN
10/10/18
NO CHANGE
Target $40
SPHN
Overweight
Stephens says now time to step in on Cutera
Stephens analyst Chris Cooley said he remains confident Cutera can deliver upon its stated 2021 objectives despite 2018 not unfolding as originally forecast as he believes truSculpt ID offers the potential to more that double the company's current share of the body contouring market by 2021. The analyst, who also thinks Cutera's margins have reached a trough and may favorably inflect exiting this year, sees now as the time to step in and reiterates his Overweight rating and $40 price target on Cutera shares.

TODAY'S FREE FLY STORIES

LIN

Linde plc

$155.03

1.58 (1.03%)

, APD

Air Products

$160.49

3.34 (2.13%)

07:33
11/16/18
11/16
07:33
11/16/18
07:33
Recommendations
Linde plc, Air Products analyst commentary  »

Linde current price…

LIN

Linde plc

$155.03

1.58 (1.03%)

APD

Air Products

$160.49

3.34 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$80.76

-2.35 (-2.83%)

, AMZN

Amazon.com

$1,620.00

20.84 (1.30%)

07:33
11/16/18
11/16
07:33
11/16/18
07:33
Initiation
Target, Amazon.com, Walmart initiated  »

Target initiated with an…

TGT

Target

$80.76

-2.35 (-2.83%)

AMZN

Amazon.com

$1,620.00

20.84 (1.30%)

WMT

Walmart

$99.62

-1.96 (-1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

AMAT

Applied Materials

$35.03

1.44 (4.29%)

, LRCX

Lam Research

$146.41

3.62 (2.54%)

07:31
11/16/18
11/16
07:31
11/16/18
07:31
Recommendations
Applied Materials, Lam Research analyst commentary  »

Applied Materials price…

AMAT

Applied Materials

$35.03

1.44 (4.29%)

LRCX

Lam Research

$146.41

3.62 (2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

VBLT

VBL Therapeutics

$1.14

-0.04 (-3.39%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Hot Stocks
VBL Therapeutics reports results from GLOBE study at SNO »

VBL Therapeutics reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

ONCE

Spark Therapeutics

$38.91

-2.02 (-4.94%)

, QURE

uniQure

$31.00

8.21 (36.02%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Upgrade
Spark Therapeutics, uniQure rating change  »

Spark Therapeutics…

ONCE

Spark Therapeutics

$38.91

-2.02 (-4.94%)

QURE

uniQure

$31.00

8.21 (36.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$55.49

1.09 (2.00%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Recommendations
Anadarko analyst commentary  »

Anadarko strategic update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

07:26
11/16/18
11/16
07:26
11/16/18
07:26
Recommendations
Nvidia analyst commentary  »

Nvidia likely to remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

AXP

American Express

$109.52

1.75 (1.62%)

, COF

Capital One

$89.21

0.29 (0.33%)

07:26
11/16/18
11/16
07:26
11/16/18
07:26
Recommendations
American Express, Capital One analyst commentary  »

American Express new top…

AXP

American Express

$109.52

1.75 (1.62%)

COF

Capital One

$89.21

0.29 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BCRX

BioCryst

$7.31

0.31 (4.43%)

07:26
11/16/18
11/16
07:26
11/16/18
07:26
Hot Stocks
BioCryst presents BCX7353 data at ACAAI meeting »

BioCryst presented data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

UBSH

Union Bankshares

$34.26

0.455 (1.35%)

07:25
11/16/18
11/16
07:25
11/16/18
07:25
Recommendations
Union Bankshares analyst commentary  »

Union Bankshares deserves…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.37

0.14 (11.38%)

07:24
11/16/18
11/16
07:24
11/16/18
07:24
Downgrade
J.C. Penney rating change  »

J.C. Penney downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

07:23
11/16/18
11/16
07:23
11/16/18
07:23
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

TPR

Tapestry

$40.99

-0.11 (-0.27%)

07:23
11/16/18
11/16
07:23
11/16/18
07:23
Recommendations
Tapestry analyst commentary  »

Tapestry price target cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

IFF

International Flavors

$142.28

1.01 (0.71%)

07:23
11/16/18
11/16
07:23
11/16/18
07:23
Initiation
International Flavors initiated  »

International Flavors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOG

GasLog

$20.02

0.17 (0.86%)

, GLOP

GasLog Partners

$24.01

0.16 (0.67%)

07:22
11/16/18
11/16
07:22
11/16/18
07:22
Hot Stocks
GasLog, GasLog Partners to modify IDR »

GasLog (GLOG) and GasLog…

GLOG

GasLog

$20.02

0.17 (0.86%)

GLOP

GasLog Partners

$24.01

0.16 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KORS

Michael Kors

$47.22

-0.77 (-1.60%)

07:21
11/16/18
11/16
07:21
11/16/18
07:21
Downgrade
Michael Kors rating change  »

Michael Kors downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

07:21
11/16/18
11/16
07:21
11/16/18
07:21
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

GAB

Gabelli Eqty Trust

$6.03

0.02 (0.33%)

07:20
11/16/18
11/16
07:20
11/16/18
07:20
Hot Stocks
Gabelli backs 10% distribution policy, raises Q4 distribution to 19c per share »

The board of The Gabelli…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.37

0.14 (11.38%)

07:20
11/16/18
11/16
07:20
11/16/18
07:20
Downgrade
J.C. Penney rating change  »

J.C. Penney downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:20
11/16/18
11/16
07:20
11/16/18
07:20
General news
FX Update: The dollar has traded mixed »

FX Update: The dollar has…

07:20
11/16/18
11/16
07:20
11/16/18
07:20
General news
Canada manufacturing preview »

Canada manufacturing…

AMAT

Applied Materials

$35.03

1.44 (4.29%)

07:19
11/16/18
11/16
07:19
11/16/18
07:19
Recommendations
Applied Materials analyst commentary  »

Citi adds Applied…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$52.33

-4.05 (-7.18%)

07:18
11/16/18
11/16
07:18
11/16/18
07:18
Recommendations
Blueprint Medicines analyst commentary  »

Blueprint Medicines data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

CUB

Cubic

$65.71

1.78 (2.78%)

07:18
11/16/18
11/16
07:18
11/16/18
07:18
Recommendations
Cubic analyst commentary  »

Cubic well positioned for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$64.59

1.09 (1.72%)

07:17
11/16/18
11/16
07:17
11/16/18
07:17
Periodicals
Citi says clients are adjusting supply chains due to trade war, CNBC reports »

Citi said their corporate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.